Bogart Wealth’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.46K Sell
18
-6
-25% -$976 ﹤0.01% 1334
2026
Q2
$3.28K Buy
24
+16
+200% +$1.97K ﹤0.01% 1325
2026
Q1
$943 Buy
+8
New +$1.12K ﹤0.01% 1464
2025
Q4
– Sell
-4
Closed -$535 – 1670
2025
Q3
$535 Buy
+4
New +$486 ﹤0.01% 1402
2025
Q2
– Sell
-3
Closed -$382 – 1529
2025
Q1
$382 Buy
+3
New +$462 ﹤0.01% 1325
2023
Q2
– Sell
-13
Closed -$2.19K – 1108
2023
Q1
$2.19K Buy
+13
New +$2.32K ﹤0.01% 893

Other funds holding RGEN

Bogart Wealth's RGEN Position: Q3 2026 in Review

Bogart Wealth reduced its Repligen (RGEN) stake by 25% in Q3 2026, selling an estimated $976 and leaving 18 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1334.

Bogart Wealth first reported a position in RGEN in Q1 2023 and has held it in 6 quarters since. 524 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Bogart Wealth held 18 shares of Repligen worth $3.46K as of Q3 2026.
  • Bogart Wealth sold 6 Repligen shares in Q3 2026, an estimated $976.
  • Repligen made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1334 holding.
  • Bogart Wealth first reported a position in Repligen in Q1 2023 and has held it in 6 quarters since.
  • 524 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.